Archives

 

CBL & Associates Properties, Inc. (NYSE: CBL)

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased CBL & Associates Properties, Inc. (“CBL” or the “Company”) (NYSE: CBL) between November 8, 2017 and March 26, 2019, inclusive (the “Class Period”). CBL shareholders may, no later than July 16, 2019, move the […]

Categories: Securities Class Action

AAC Holdings, Inc. (NYSE: AAC)

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased AAC Holdings, Inc. (“AAC” or the “Company”) (NYSE: AAC) between March 8, 2017 and April 15, 2019, inclusive (the “Class Period”). AAC shareholders may, no later than July 15, 2019, move the Court for […]

Categories: Securities Class Action

Nutanix, Inc. (NYSE: NTNX)

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Nutanix, Inc. (“Nutanix” or the “Company”) (NYSE: NTNX) between March 8, 2017 and April 15, 2019, inclusive (the “Class Period”). Nutanix shareholders may, no later than May 28, 2019, move the Court for appointment […]

Categories: Securities Class Action

Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX)

RM LAW, P.C. announces an investigation on behalf of Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) (“Allscripts” or the “Company”) investors concerning the Company and its officers’ possible violations of federal securities laws. If you purchased shares of Allscripts and would like to learn more about these claims or if you wish to discuss these matters […]

Categories: Securities Class Action

Interface, Inc. (NASDAQ: TILE)

RM LAW, P.C. announces an investigation on behalf of Interface, Inc. (NASDAQ: TILE) (“Interface” or the “Company”) investors concerning the Company and its officers’ possible violations of federal securities laws. If you purchased shares of Interface and would like to learn more about these claims or if you wish to discuss these matters and have […]

Categories: Securities Class Action

KushCo Holdings, Inc. (OTC: KSHB)

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased KushCo Holdings, Inc. (“KushCo” or the “Company”) (OTC: KSHB) between July 13, 2017 and April 9, 2019, inclusive (the “Class Period”). KushCo shareholders may, no later than July 1, 2019, move the Court for […]

Categories: Securities Class Action

Lyft, Inc. (NASDAQ: LYFT)

RM LAW, P.C. announces an investigation on behalf of Lyft, Inc. (“Lyft” or the “Company”) (NASDAQ: LYFT) investors who purchased Lyft pursuant or traceable to the Company’s Offering and Registration Statement issued in relation to the March 28, 2019 Initial Public Offering (”IPO”). If you purchased shares of Lyft and would like to learn more […]

Categories: Securities Class Action

Village Farms International, Inc. (NASDAQ: VFF)

RM LAW, P.C. announces an investigation on behalf of Village Farms International, Inc. (NASDAQ: VFF) (“Village Farms” or the “Company”) investors concerning the Company and its officers’ possible violations of federal securities laws. If you purchased shares of Village Farms and would like to learn more about these claims or if you wish to discuss […]

Categories: Securities Class Action

Conagra Brands, Inc. (NYSE: CAG)

RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Conagra Brands, Inc. (“Conagra” or the “Company”) (NYSE: CAG) between June 27, 2018 through December 19, 2018, inclusive (the “Class Period”) to specifically include legacy Pinnacle Foods, Inc. (“Pinnacle”) common stock holders who received […]

Categories: Securities Class Action

Eidos Therapeutics, Inc. (NASDAQ: EIDX)

RM LAW, P.C. announces an investigation on behalf of Eidos Therapeutics, Inc. (NASDAQ: EIDX) (“Eidos Therapeutics” or the “Company”) investors concerning the Company and its officers’ possible violations of federal securities laws. If you purchased shares of Eidos Therapeutics and would like to learn more about these claims or if you wish to discuss these […]

Categories: Securities Class Action